Video

GLP-1 Receptor Agonists in Your Toolkit

Author and Disclosure Information

 

References

Davida F. Kruger explains the use of short- and long-acting GLP-1 receptor agonists in the management of diabetes.

This video provides three takeaways in less than three minutes from the presentation the 2015 MEDS conference, entitled “Incorporating GLP-1 Receptor Agonists Into Your Diabetes Toolkit: Improving Adherence and Patient Outcomes” co-presented by Holly Jodon, MPAS, PA-C, DFAAPA and supported by Creative Educational Concepts, Inc. and an independent educational grant from AstraZeneca.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

Recommended Reading

EASD: Monthly incretin-based therapy shows promise in type 2 diabetes
Type 2 Diabetes ICYMI
EASD: Once-weekly omarigliptin as effective as daily sitagliptin
Type 2 Diabetes ICYMI
EASD: Once-weekly omarigliptin as effective as daily sitagliptin
Type 2 Diabetes ICYMI
Progress in treating diabetic foot osteomyelitis
Type 2 Diabetes ICYMI
ESC: Strong coffee raises hypertension and prediabetes risk
Type 2 Diabetes ICYMI
EASD: Studies slam cardiovascular safety of sulfonylureas
Type 2 Diabetes ICYMI
Children with metabolic syndrome at higher risk for diabetes
Type 2 Diabetes ICYMI
TCT: Everolimus stents best paclitaxel for diabetes patients
Type 2 Diabetes ICYMI
Monthly Incretin-based Therapy Shows Promise in Type 2 Diabetes
Type 2 Diabetes ICYMI
Progress in Treating Diabetic Foot Osteomyelitis
Type 2 Diabetes ICYMI